Bruker Q1 Revenues up 8 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Bruker reported after the close of the market Wednesday that its revenues in the first quarter were up 8 percent year over year, rising to $423.7 million from $393.4 million in Q1 2013.

The results beat the average Wall Street estimate of $402.0 million. Acquisitions and divestitures were responsible for a net positive effect of roughly 1 percent, while foreign currency effects were negligible in the quarter, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.